Inventor · disambiguated record
Kensuke Nakamura
Also filed as: NAKAMURA KENSUKE
24 granted patents·9 pending applications·39 citations·filing 2016–2025
93Inventor score
Files withDAIICHI SANKYO CO LTD24UNIV MIE3UNIV SAITAMA MEDICAL3UNIV KOBE NAT UNIV CORP2DAIICHI SANKYO COMPANY LIMTED1
Top patents by PatentIndex Score
33 records- 0196US10906974B2Anti-GPR20 antibody and anti-GPR20 antibody-drug conjugateDAIICHI SANKYO CO LTD·Filed 2020·Granted Feb 2, 2021·9 cites·30 claims
- 0293US10428148B2Anti-ALK2 antibodyUNIV SAITAMA MEDICAL·Filed 2016·Granted Oct 1, 2019·21 cites·12 claims
- 0390US12246196B2Antibody-drug conjugates comprising substituted benzo[e]pyrrolo[1,2-a][1,4]diazepinesDAIICHI SANKYO CO LTD·Filed 2022·Granted Mar 11, 2025·1 cites·34 claims
- 0489US11583590B2Antibody-pyrrolobenzodiazepine derivative conjugate and method of use thereof for treating a tumorDAIICHI SANKYO CO LTD·Filed 2021·Granted Feb 21, 2023·1 cites·30 claims
- 0589US11077202B2Anti-CDH6 antibody and anti-CDH6 antibody-drug conjugateDAIICHI SANKYO CO LTD·Filed 2020·Granted Aug 3, 2021·2 cites·30 claims
- 0687US11091560B2Anti-human TLR7 antibodyDAIICHI SANKYO CO LTD·Filed 2020·Granted Aug 17, 2021·2 cites·28 claims
- 0784US2025114647A1ANTIBODY-DRUG CONJUGATES COMPRISING SUBSTITUTED BENZO[e]PYRROLO[1,2-a][1,4]DIAZEPINESDAIICHI SANKYO COMPANY LIMTED·Filed 2024·Application pending·0 cites
- 0883US11628223B2Antibody-drug conjugates comprising substituted benzo[e]pyrrolo[1,2-α][1,4]diazepinesDAIICHI SANKYO CO LTD·Filed 2018·Granted Apr 18, 2023·1 cites·1 claims
- 0979US12233155B2Polynucleotides encoding antibodies which bind the EC3 domain of cadherin-6 (CDH6) and possess internalization abilityDAIICHI SANKYO CO LTD·Filed 2022·Granted Feb 25, 2025·0 cites·10 claims
- 1078US12486329B2Anti-SIRPα antibodyUNIV KOBE NAT UNIV CORP·Filed 2024·Granted Dec 2, 2025·0 cites·21 claims
- 1178US12350344B2Methods of treating a tumor by administering a claudin-6 (CLDN6) or CLDN9 antibody-pyrrolobenzodiazepine derivative conjugateDAIICHI SANKYO CO LTD·Filed 2022·Granted Jul 8, 2025·0 cites·36 claims
- 1277US10647769B1Antibody for treating autoimmune diseasesDAIICHI SANKYO CO LTD·Filed 2019·Granted May 12, 2020·1 cites·27 claims
- 1376US11952423B2Bispecific antibodyUNIV MIE·Filed 2023·Granted Apr 9, 2024·0 cites·28 claims
- 1475US2024400681A1Method for producing an anti-lag-3 antibodyDAIICHI SANKYO CO LTD·Filed 2024·Application pending·0 cites
- 1572US2025282889A1Bispecific antibodyUNIV MIE·Filed 2025·Application pending·0 cites
- 1671US11001819B2Endos mutant enzymeDAIICHI SANKYO CO LTD·Filed 2016·Granted May 11, 2021·1 cites·14 claims
- 1771US2023212306A1Anti-human tlr7 antibodyDAIICHI SANKYO CO LTD·Filed 2022·Application pending·0 cites
- 1868US11578138B2Anti-human TLR7 antibodyDAIICHI SANKYO CO LTD·Filed 2021·Granted Feb 14, 2023·0 cites·39 claims
- 1968US11447554B2Anti-ALK2 antibodyUNIV SAITAMA MEDICAL·Filed 2021·Granted Sep 20, 2022·0 cites·27 claims
- 2068US11446386B2Anti-CDH6 antibody and method of producing an anti-CDH6 antibody-drug conjugateDAIICHI SANKYO CO LTD·Filed 2018·Granted Sep 20, 2022·0 cites·18 claims
- 2168US2025228766A1Polynucleotides encoding antibodies which bind the ec3 domain of cadherin-6 (cdh6) and possess internalization abilityDAIICHI SANKYO CO LTD·Filed 2025·Application pending·0 cites
- 2267US2023287119A1Anti-cd3 antibody and molecules comprising the antibodyDAIICHI SANKYO CO LTD·Filed 2023·Application pending·0 cites
- 2366US12344674B2Bispecific antibodyUNIV MIE·Filed 2021·Granted Jul 1, 2025·0 cites·18 claims
- 2465US12024566B2Anti-SIRPalpha antibodyUNIV KOBE NAT UNIV CORP·Filed 2019·Granted Jul 2, 2024·0 cites·29 claims
- 2563US11312776B2Anti-ALK2 antibodyUNIV SAITAMA MEDICAL·Filed 2019·Granted Apr 26, 2022·0 cites·9 claims
- 2659US11618785B2Anti-CD3 antibody and molecules comprising the antibodyDAIICHI SANKYO CO LTD·Filed 2017·Granted Apr 4, 2023·0 cites·41 claims
- 2756US11434289B2Anti-GPR20 antibody and anti-GPR20 antibody-drug conjugateDAIICHI SANKYO CO LTD·Filed 2018·Granted Sep 6, 2022·0 cites·44 claims
- 2855US12071478B2Methods for treating autoimmune diseases incorporating an anti-LAG3 antibodyDAIICHI SANKYO CO LTD·Filed 2017·Granted Aug 27, 2024·0 cites·11 claims
- 2954US2024182569A1Stable multispecific molecule and use thereofDAIICHI SANKYO CO LTD·Filed 2022·Application pending·0 cites
- 3052US11261249B2Anti-GPR20 antibodyDAIICHI SANKYO CO LTD·Filed 2018·Granted Mar 1, 2022·0 cites·17 claims
- 3152US2023248819A1Nucleic acid lipid particle vaccineDAIICHI SANKYO CO LTD·Filed 2021·Application pending·0 cites
- 3242US11208442B2Endo-beta-N-acetylglucosaminidaseDAIICHI SANKYO CO LTD·Filed 2017·Granted Dec 28, 2021·0 cites·12 claims
- 3339US2019367612A1Anti-gprc5d antibody and molecule containing sameDAIICHI SANKYO CO LTD·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kensuke Nakamura files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →